ABBVIE |
Spain |
AbbVie Deutschland GmbH & Co KG |
Germany |
Advent France Biotechnology |
France |
Alta Life Sciences |
Spain |
ARCH Venture Partners |
United States |
Asabys Partners |
Spain |
Aurora Science |
Italy |
Bayer |
Spain |
BME Growth |
Spain |
Boehringer Ingelheim Pharma |
Germany |
Caixa Capital Risc |
Spain |
Capital Cell |
Spain |
Clave Mayor |
Spain |
Columbus Venture Partners |
Spain |
CR Ventures |
United States |
ECBF – European Circular Bioeconomy Fund |
Germany |
Euronext |
France |
Forty51ventures |
Switzerland |
Fund+ |
Belgium |
Grifols, S.A. |
Spain |
Inveready |
Spain |
InVivo Capital |
Spain |
IPF Partners |
Switzerland |
Keensight Capital |
France |
Kurma Partners |
France |
Merck Ventures Bv |
Netherlands |
MSD |
United Kingdom |
Norgine Ventures |
United Kingdom |
Nowture |
Spain |
Omnes Capital |
France |
Remiges Ventures |
United States |
Sanofi-Aventis Deutschland GmbH |
Germany |
Seventure |
France |
Sodena |
Spain |
Ultreum Life Science Dmcc |
United Arab Emirates |
Unirisco Galicia SCR |
Spain |
Ventac Partners |
Spain |
Wellington Partners |
Germany |
Ysios Capital Partners |
Spain |